CENP-50 is required for papilloma development in the two-stage skin carcinogenesis model

Cancer Science
Megumi SaitoYuichi Wakabayashi

Abstract

CENP-50/U is a component of the CENP-O complex (CENP-O/P/Q/R/U) and localizes to the centromere throughout the cell cycle. Aberrant expression of CENP-50/U has been reported in many types of cancers. However, as Cenp-50/U-deficient mice die during early embryogenesis, its functions remain poorly understood in vivo. To investigate the role of Cenp-50/U in skin carcinogenesis, we generated Cenp-50/U conditional knockout (K14CreER -Cenp-50/Ufl/fl ) mice and subjected them to the 7,12-dimethylbenz(a)anthracene (DMBA)/terephthalic acid (TPA) chemical carcinogenesis protocol. As a result, early-stage papillomas decreased in Cenp-50/U-deficient mice. In contrast, Cenp-50/U-deficient mice demonstrated almost the same carcinoma incidence as control mice. Furthermore, mRNA expression analysis using DMBA/TPA-induced papillomas and carcinomas revealed that Cenp-50/U expression levels in papillomas were significantly higher than in carcinomas. These results suggest that Cenp-50/U functions mainly in early papilloma development and it has little effect on malignant conversion.

References

Mar 21, 1998·Human Molecular Genetics·T Fukagawa, W R Brown
Mar 14, 1998·Proceedings of the National Academy of Sciences of the United States of America·P KalitsisK H Choo
Jan 1, 1999·Nature·C LengauerB Vogelstein
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·V VasioukhinE Fuchs
Feb 3, 2000·Proceedings of the National Academy of Sciences of the United States of America·E V HowmanK H Choo
Oct 12, 2001·Hormone Research·A K IndraD Metzger
Sep 2, 2003·The Journal of Pathology·Eiki MiyajiSaburo Onishi
Jun 17, 2005·Cancer Research·Diane R Wonsey, Maximillian T Follettie
Jul 26, 2005·Seminars in Cancer Biology·Christopher J Kemp
Aug 9, 2005·Molecular Carcinogenesis·Erik WilkerJohn DiGiovanni
Nov 17, 2005·Molecular and Cellular Biology·Yukinori MinoshimaTatsuo Fukagawa
Dec 21, 2007·Molecular Biology of the Cell·Tetsuya HoriTatsuo Fukagawa
Dec 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Panomwat AmornphimolthamJ Silvio Gutkind
Aug 29, 2009·Nature Protocols·Erika L AbelJohn DiGiovanni
Dec 17, 2009·Molecular Cancer·Angela AmatoAldo Di Leonardo
Feb 22, 2011·Cell·Ben E Black, Don W Cleveland
Jul 14, 2011·Chromosoma·Marinela Perpelescu, Tatsuo Fukagawa
May 29, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jun-Jun QiuKe-Qin Hua
Feb 1, 2014·Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology·Naoko KagawaTatsuo Fukagawa
Sep 10, 2014·Developmental Cell·Tatsuo Fukagawa, William C Earnshaw
Apr 12, 2016·International Journal of Cancer. Journal International Du Cancer·Xia SunSifeng Qu
Feb 25, 2018·Current Opinion in Cell Biology·Masatoshi Hara, Tatsuo Fukagawa

❮ Previous
Next ❯

Citations

Mar 30, 2021·Experimental Animals·Kazuhiro OkumuraYuichi Wakabayashi

❮ Previous
Next ❯

Methods Mentioned

BETA
chemical treatment
electrophoresis
Protein Assay

Software Mentioned

GraphPad
GraphPad Prism

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.